indomethacin , administered subcutaneously at a dose of 6 mg/kg on day 3 or 4 of pregnancy and intraluminally at a dose of 800 micrograms/rat on day 4 of pregnancy , also significantly reduced uterine prostaglandin levels .
C0021246
indomethacin
C0032961
pregnancy